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Two independent colchicine (CLC)-resistant sublines of Rous sarcoma virus-transformed Syrian hamster fibroblasts were isolated. Each subline 
represented variants with 11- and 12.4-fold resistance, respectively, their 23- and 23.7-fold resistant descendants, as well as variants cultured in 
CLC-free medium for 10 months without loss of resistance. All variants demonstrated ‘typical’ multidrug resistance. The parental cells contained 
actin in dispersed form, as determined by rhodamine-phalloidin staining. In contrast, already in 1 l- and 12.4-fold resistant sublines up to 30% of 
cells demonstrated restored stress fibers. Cultivation in CLC-free medium leads to the accumulation of cells with a partially restored actin cytoskeleton. 
Putative mechanisms of up-regulation of stress fiber assembly in cells with P-glycoprotein-mediated multidrug resistance are discussed. 
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1. Introduction 
Multidrug resistance is one of the main reasons for 
chemotherapeutic failures in cancer patients. ‘Typical’ 
MDR (T-MDR) is characterized by the following phe- 
nomena: (i) cells selected for insensitivity to a single drug 
demonstrate cross-resistance to certain agents; (ii) intra- 
cellular drug accumulation is decreased; (iii) 140-170 
kDa transmembrane Pgp is overexpressed [l]. The Pgp- 
mediated efflux of cytostatics is considered to be the 
major mechanism that defines T-MDR. 
The evolution of T-MDR is accompanied by signifi- 
cant alterations of cellular morphology and physiology, 
e.g. changes in cell spreading, growth rate, membrane 
traffic, decrease of tumorigenicity and metastatic capa- 
bility, etc. [2-51. These characteristics of cell behavior are 
mediated, at least in part, by the actin cytoskeleton (see 
[6,7] for reviews). Partial restoration of the actin cy- 
toskeleton in cells with a high level of drug resistance 
have been shown previously [5]. However, phenotypic 
alterations may already arise in cells with low levels of 
drug resistance; so, we suggested that certain changes of 
*Corresponding author. 
Abbreviations: CLC, colchicine; PAGE, polyacrilamide gel electropho- 
resis; PBS, phosphate-buffered saline; Pgp, P-glycoprotein; RSV, Rous 
sarcoma virus; SDS, sodium dodecyl sulfate; T-MDR, ‘typical’ mul- 
tidrug resistance. 
the actin cytoskeleton might emerge just at the early 
steps of selection for T-MDR. 
2. Materials and methods 
2.1. Cell lines 
The HET-SR-ZSC-LNM line, the Syrian hamster embryo fibroblasts 
transformed by RSV, Schmidt-Ruppin strain, was provided by Prof. 
G. Deichman, Cancer Research Center, Moscow. This line was used 
as the parental ine for the isolation of drag-resistant variants. Cells 
were propagated in RPMI-1640 plus Dulbecco’s modified Eagle’s me- 
dium (l:l, v/v) supplemented with 5% fetal calf serum (Flow), 2 mM 
L-glutamine and 50 U/ml gentamycin (complete medium). For the iso- 
lation of sublines with T-MDR, the parental cells were continuously 
treated with increasing concentrations of CLC (Merck, Germany). 
CLC-resistant sublines were propagated in complete medium supple- 
mented with CLC. 
2.2. Cell viability in the presence of cytostatic drugs 
Cell viability in the presence of cytostatic drugs was studied in an 
MTT-assay as described elsewhere [8]. The drugs used were CLC, 
vinblastine (G. Richter, Hungary); Farmorubicin (Farmitalia Carlo 
Erba, Italy); methotrexate and Platidiam (Lachema, Czechoslovakia). 
I& 50% growth inhibition concentration, and resistance levels were 
calculated as indicated in legend to Table 1. 
2.3. In vitro drug uptake 
5 x 10’ cells/~~~I were plated onto 24-well plates (Costar) and incu- 
bated overnight at 37’C, 5% CO*, [‘HlVincristine (10e6 M, 0.037 MBk; 
Amersham) or Farmorubicin (10m6 M) were added. Parallel wells were 
coincubated with drug and T-MDR-reversing agent Finoptin (5 x 10m6 
M, Orion). After 30 min incubated cell monolayers were washed 3 times 
with cold PBS, pH 7.2. For the study of farmorubicin accumulation, 
cells were lysed in 0.3 N HCl in 50% ethanol and spun (100 x g, 30 min). 
Supematants were assayed with a Hitachi spectrofluorimeter (exitation 
470 nm, emission 585 nm) [9]. Drug content was estimated using stand- 
ard calibrating curves. For the study of [3H]vincristine uptake, cells 
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were lysed in 0.5 N NaOH overnight at 37°C and radioactivity of the 
samples was measured with a/?-counter (LKB). Protein concentrations 
were measured by the method of Lowry [lo]. 
2.4. Western blot detection of Pgp 
Cells were detached from culture plastic, pelleted and lysed in buffer 
(10% sucrose; 62.5 mM Tris, pH 6.8; 2 mM EDT& 2% SDS; 2 mM 
PMSF). Further steps of lysate preparation and electroblotting were 
performed as described 1111. Nitrocellulose tilters were probed with 
murine monoclonal antibodies C219 (Sighet Lab. Inc., a gift from Prof. 
M. Dietel, Christian-Albrecht’s Universitiit, Kiel). Bound antibodies 
were detected, using rabbit anti-mouse antibodies coupled with perox- 
idase and a substrate mixture containing 4-chloro-naphtol (Sigma). 
2.5. Immunocytochemistry 
Rhodamine-phalloidin staining of F-actin was carried out exactly as 
described [121. Cells were examined under a Photomicroscope 3 (Gpton, 
Germany) and photographed. 500 cells of each subline were examined 
in different fields of coverslips, and the percentage of cells demonstrat- 
ing stress fibers was calculated. 
3.Results 
The selective procedure and drug resistance levels of 
cells used in this study are shown in Table 1. Two inde- 
pendent CLC-resistant sublines (variants with 11; 12.4 
and 23; 23.7-fold resistance to CLC) were isolated in 
vitro from the wild type HET-SR-2SC-LNM cell line by 
step-wise selection. In addition, 2SC/20R-1 and 2SC/ 
20R-2 sublines were maintained; these derivatives of 
2SC/20-1 and 2SC/20-2 sublines, respectively, were cul- 
Table 1 
Isolation of CLC-resistant sublines from HET-SR-ZSC-LNM line 
Cell line Origin Duration of I&, 
CLC treatment @g/ml) 
(weeks)* 
HET-SR-ZSC- 
LNM 
(parental) 
2sc/4-1 
2sc/4-2 
2sc/20-1 
2sc/20-2 
2SC/20R-1 
2SC/20R-2 
_ 
selected from paren- 
tal at 4 ,ug/ml 
selected from paren- 
tal at 4 &ml 
selected from 2SC/4-1 
at 20 &ml 
selected from 2X/4-2 
at 20 fig/ml 
2SC/20-1 propagated 
in CLC-free medium 
for 10 months 
2SCY20-2 propagated 
in CLC-free medium 
for 10 months 
0.36 dz 0.03 
(1) 
3 4.47 zb 0.47 
(12.4) 
5 3.95 * 0.39 
(11) 
6 8.27 f 0.27 
(23.0) 
6 8.55 f 0.09 
(23.7) 
6 8.15 + 0.11 
(22.6) 
6 8.20 f 0.09 
(22.8) 
IC,, a 50% growth inhibition concentration, mean & S.E. from 3 exper- 
iments. 
*After step-wise selection all CLCresistant sublines were propagated 
in complete medium containing CLC. The drug was omitted from the 
medium l-2 passages prior to the determination of IC,,. 
of resistant subline 
Resistance levels 
I& of parental ine 
are given in parentheses. 
Fig. 1. Western blot assay of P-glycoprotein. Cell lysates were resolved 
by SDS-PAGE, electroblotted and probed with C219 antibodies di- 
rected to P-glycoprotein. Lanes 1, HET-SR-ZSC-LNM; 2,2SC/4-1; 3, 
2SCl4-2; 4, 2X/20-1; 5, 2SCl20-2; 6, 2SC/20R-1; I, 2SC/20R-2. The 
molecular weight (in kDa) is indicated at the right of the panel. 
tured in CLC-free medium for 10 months but did not lose 
CLC-resistance (Table 1). 
Pgp was clearly detected in 2SC/20-1 and 2SC/20-2 
cells as well as in both 2SC/20R sublines (Fig. l), as 
detected by Western blotting with anti-Pgp antibodies. 
The resistant sublines demonstrated cross-resistance to 
vinblastine, Farmorubicin, but not to methotrexate or 
Platidiam (Table 2). The uptake of MDR-related drugs, 
3H-vincristine and farmorubicin, in 2SC/20-1 and 2SC/ 
20-2 sublines was significantly lower than in parental 
cells, and was Gnoptin-reversible (Table 3). Taken to- 
gether, these data indicate that the selected sublines dem- 
onstrated characteristic patterns of T-MDR. 
We used the rhodamine-phalloidin staining to study 
the actin cytoskeleton in wild type (drug-sensitive) cells 
and their variants with T-MDR. Parental HET-SR-2SC- 
LNM fibroblasts shared intensive diffuse cytoplasmic 
staining (Fig. 2A,B). We failed to visualize stress fibers 
in parental cells. In contrast, 25-308 of the variants in 
the 2SC/4-1, 2SC/4-2 and 2SC/20-1, 2SC/20-2 sublines 
demonstrated microlilamentous bundles crossing the cell 
(Fig. 2C,D). 
Table 2 
I& (@ml) and cross-resistance l vels (in parentheses) of HET-SR- 
ZSC-LNM cells and CLC-resistant variants 
Cell line Drugs 
Farmorubicin Vinblastine Methotrexate Platidiam 
HET-SR- 125 5 31 700 
2SC-LNM 
2sc/20- 1 2875 135 
(23) (27) ;:7) :; 
2sc/20-2 2375 490 
(19) (0.7) 
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Fig. 2. Rhodamine-phalloidin staining of HET-SR-2SC-LNM cells and sublines with T-MDR. (A,B) HET-SR-ZSC-LNM cells, diffuse cytoplasmic 
staining. (C) 2SC/4-2 subline: cell with stress fibers and variants with diffuse staining; (D) 2SC/20-2 cell, stress fibers crossing the cell. (A,C) x 700; 
(B,D) x 2100. 
In both 2SC/20R-1 and 2SC/20R-2 sublines, cultured 
in CLC-free medium for a long period without loss of 
resistance and Pgp overexpression (see Table 1, Fig. l), 
the increased number of cells with partially restored actin 
was found. The majority of cells (more than 50% of the 
cell population) had clearly visualized stress fibers. 
4. Discussion 
In the present study we isolated RSV-transformed ro- 
dent fibroblasts with low levels of CLC-resistance. These 
sublines are shown to possess T-MDR, providing evi- 
dence that Pgp-mediated drug efllux did confer drug 
resistance in this experimental model. 
Our major result is the tendency for partial restoration 
of the actin cytoskeleton in cells with initial levels of 
T-MDR. The data imply that the establishment of Pgp- 
mediated MDR may be accompanied by the restoration 
of stress fibers, and these changes are inherited by subse- 
quent cell generations. 
Thus, the restoration of the actin cytoskeleton in the 
course of selection for T-MDR seems to be non-random. 
The question arises: are there mechanisms common for 
the up-regulation of both Pgp-mediated rug e&tx and 
actin restoration? We suggest that least three mecha- 
nisms directly associated with the establishment of T- 
MDR, e.g. the increase in intracellular energy turnover, 
elevation of the Ca*+ influx, and activation of protein 
kinase C, may account for actin assembly. 
First, T-MDR cells need more intracellular ATP, since 
Pgp-mediated drug etBux requires greater amounts of 
ATP [13]. On the other hand, ATP is crucial for the 
elongation of actin monomers [14], and a rapid increase 
in ATP consumption leads to the restoration of actin 
[15]. Probably, the increase of energy supply in cells with 
T-MDR may be the background for the assembly of 
stress fibers. 
Second, the increased Ca*+ influx observed in cells 
with T-MDR [16] may lead to inactivation of capping 
proteins, thus promoting nucleation [17]. So excess of 
ATP and Ca*’ at the cell periphery could attribute to the 
initiation of F-actin restoration. 
Third, one could propose a phosphatidylinositol 4,5- 
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Table 3 References 
Uptake of drugs by HET-SR-2SC-LNM cells and 2SC/20 sublines 
Cell line 10e6 M [3H]Vincristine low6 M Farmorubicin 111 
- Finoptin + Finoptin - Finoptin + Finoptin 
Beck, W. (1991) in: Molecular and Cellular Mechanisms of Mul- 
tidrug Resistance in Tumor Cells (Roninson, I. Ed.) Plenum Press, 
New York. 
HET-SR- 16.1 f 1.2 22.3 f 1.1 28.8 f 1.5 32.2 + 2.1 
ZSC-LNM 
2sc/20-1 6.6 f 0.4” 15.7 + 0.2b 9.7 f 0.6” 28.6 ?r 1.5b 
2SCl20-2 7.4 f 0.1” 13.0 + 0.5b 11.0 f 0.4” 27.4 f 1.3b 
Cells were incubated either with drug only or with drug and 5 x 10e6 
M Finoptin for 30 min, washed, lysed, and the drug content was deter- 
mined (see section 2). *Significantly different (by Student’s r-test) from 
HET-SR-2SC-LNM cells (P < 0.05); bsignhicantly different from cells 
incubated without Fmoptin (P c 0.05). 
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